Eksigent Technologies, LLC (Dublin, California) announced that David Weber has joined the company as CEO, president, and director.
Eksigent Technologies, LLC (Dublin, California) announced that David Weber has joined the company as CEO, president, and director.
Weber joins the company from Stratagene Corporation (San Diego, California), where he was vice-president of Global Marketing and Business Development.
Weber brings 30 years experience in the life science and biotechnology industries, with sales and marketing positions at companies ranging in size from start-up to over $300 million in annual sales.
LC–MS/MS-Based System Used to Profile Ceramide Reactions to Diseases
April 26th 2024Scientists from the University of Córdoba in Córdoba, Spain recently used liquid chromatography–tandem mass spectrometry (LC–MS/MS) to comprehensively profile human ceramides to determine their reactions to diseases.
High-Throughput 4D TIMS Method Accelerates Lipidomics Analysis
April 25th 2024Ultrahigh-pressure liquid chromatography coupled to high-resolution mass spectrometry (UHPLC-HRMS) had been previously proposed for untargeted lipidomics analysis, but this updated approach was reported by the authors to reduce run time to 4 min.